A large study from Japan shows no significant protective effect of low-dose aspirin against cardiovascular mortality among people with risk factors (but no prior CVD history). Now what should doctors advise?
Î²-blockers have been a keystone of treatments for heart patients for 35 years, although side-effects were not uncommon. Now a new study may shift doctors away from this standard therapy.
A new drug combination appears to reduce the toll of heart failure by almost one-fifth. Some caveats warrant attention, but for such a common, lethal condition, this therapy may change the standard of care if confirmed.
In a new study of data from the long-term Nurses Health Study (women) and the Health Professionals Follow-up Study (men), Dr. Ying Bao and colleagues from Harvard Medical School and affiliates found a strong association between consumption of various types of nuts and a decreased risk of death.
A very large metaanalysis of the putative efficacy of supplements to prolong life showed no beneficial effects, and perhaps a slight detrimental effect. There are no valid studies supporting the general use of such substances.
Women typically live longer than men in most parts of the world. This is thought to be due to biological, dietary, and behavioral differences, but the exact explanation is unknown.